Patents by Inventor Glenn Richard Carlson

Glenn Richard Carlson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
    Patent number: 7456315
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: November 25, 2008
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Multiple inducible gene regulation system
    Publication number: 20020110861
    Abstract: The present invention relates to the field of biotechnology or genetic engineering. More specifically, the present invention relates to a multiple inducible gene regulation system that functions within cells to simultaneously control the quantitative expression of multiple genes.
    Type: Application
    Filed: September 27, 2001
    Publication date: August 15, 2002
    Inventors: Tarlochan Singh Dhadialla, Dean Ervin Cress, Glenn Richard Carlson, Robert Eugene Hormann, Subba Reddy Palli, Arthur John Kudla, Ronald Phillip Herzig, Mohan Philip
  • Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
    Publication number: 20010044151
    Abstract: This invention relates to an improved method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene. The improvement resides in a select group of non-steroid ligands which show improved activity over known ligands.
    Type: Application
    Filed: April 12, 2001
    Publication date: November 22, 2001
    Inventors: Glenn Richard Carlson, Dean Ervin Cress, Tarlochan Singh Dhadialla, Robert Eugene Hormann, Dat Phat Le
  • Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
    Patent number: 6258603
    Abstract: This invention relates to an improved method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene. The improvement resides in a select group of non-steroid ligands which show improved activity over known ligands.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: July 10, 2001
    Assignee: Rohm and Haas Company
    Inventors: Glenn Richard Carlson, Dean Ervin Cress, Tarlochan Singh Dhadialla, Robert Eugene Hormann, Dat Phat Le